Variant report
Variant | esv3360687 |
---|---|
Chromosome Location | chr8:143961080-143998221 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:142)
- CpG islands (count:428)
- Chromatin interactive region (count:7)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BATF | chr8:143987622-143987828 | GM12878 | blood: | n/a | chr8:143987764-143987775 |
2 | BHLHE40 | chr8:143975332-143975632 | HepG2 | liver: | n/a | n/a |
3 | BHLHE40 | chr8:143975344-143975622 | K562 | blood: | n/a | n/a |
4 | CBX3 | chr8:143993340-143993685 | K562 | blood: | n/a | n/a |
5 | CEBPB | chr8:143975315-143975613 | Hela-S3 | cervix: | n/a | n/a |
6 | CHD2 | chr8:143968205-143968520 | K562 | blood: | n/a | n/a |
7 | CTCF | chr8:143994622-143994697 | Hela-S3 | cervix: | n/a | chr8:143994656-143994665 chr8:143994632-143994645 |
8 | CTCF | chr8:143968885-143968916 | K562 | blood: | n/a | n/a |
9 | CTCF | chr8:143994720-143994870 | GM12871 | blood: | n/a | n/a |
10 | CTCF | chr8:143994568-143994734 | GM12891 | blood: | n/a | chr8:143994656-143994665 chr8:143994632-143994645 |
11 | CTCF | chr8:143994581-143994712 | K562 | blood: | n/a | chr8:143994656-143994665 chr8:143994632-143994645 |
12 | CTCF | chr8:143994586-143994696 | GM19238 | blood: | n/a | chr8:143994656-143994665 chr8:143994632-143994645 |
13 | CTCF | chr8:143987000-143987150 | GM12875 | blood: | n/a | n/a |
14 | CTCF | chr8:143994599-143994742 | GM10248 | blood: | n/a | chr8:143994656-143994665 chr8:143994632-143994645 |
15 | CTCF | chr8:143994563-143994638 | GM12892 | blood: | n/a | n/a |
16 | CTCF | chr8:143988720-143988870 | HCT-116 | colon: | n/a | n/a |
17 | CTCF | chr8:143961678-143961759 | GM20000 | blood: | n/a | n/a |
18 | CUX1 | chr8:143977763-143977837 | K562 | blood: | n/a | n/a |
19 | EBF1 | chr8:143997953-143998106 | GM12878 | blood: | n/a | n/a |
20 | EBF1 | chr8:143989032-143989208 | GM12878 | blood: | n/a | n/a |
21 | EBF1 | chr8:143979537-143979979 | GM12878 | blood: | n/a | n/a |
22 | EGR1 | chr8:143993744-143994024 | K562 | blood: | n/a | chr8:143993918-143993932 chr8:143993919-143993932 chr8:143993920-143993929 chr8:143993925-143993938 chr8:143993919-143993932 chr8:143993919-143993932 chr8:143993919-143993929 chr8:143993914-143993936 chr8:143993923-143993933 chr8:143993877-143993887 chr8:143993918-143993933 chr8:143993919-143993932 |
23 | EGR1 | chr8:143993819-143994054 | K562 | blood: | n/a | chr8:143993918-143993932 chr8:143993919-143993932 chr8:143993920-143993929 chr8:143993925-143993938 chr8:143993919-143993932 chr8:143993919-143993932 chr8:143993919-143993929 chr8:143993914-143993936 chr8:143993923-143993933 chr8:143993877-143993887 chr8:143993918-143993933 chr8:143993919-143993932 |
24 | ELF1 | chr8:143993227-143993853 | MCF-7 | breast: | n/a | chr8:143993487-143993500 |
25 | ELF1 | chr8:143993382-143993601 | HepG2 | liver: | n/a | chr8:143993487-143993500 |
26 | ELF1 | chr8:143993285-143993676 | K562 | blood: | n/a | chr8:143993487-143993500 |
27 | ELK1 | chr8:143983813-143983816 | Hela-S3 | cervix: | n/a | n/a |
28 | EP300 | chr8:143987188-143987251 | K562 | blood: | n/a | n/a |
29 | EP300 | chr8:143979443-143980098 | GM12878 | blood: | n/a | n/a |
30 | FOSL2 | chr8:143979468-143980152 | HepG2 | liver: | n/a | n/a |
31 | FOXA2 | chr8:143979465-143980049 | A549 | lung: | n/a | n/a |
32 | FOXP2 | chr8:143983504-143983917 | SK-N-MC | brain: | n/a | n/a |
33 | GABPA | chr8:143979778-143980075 | Hela-S3 | cervix: | n/a | n/a |
34 | GABPA | chr8:143979480-143979775 | Hela-S3 | cervix: | n/a | n/a |
35 | GATA1 | chr8:143975138-143975670 | PBDE | blood: | n/a | n/a |
36 | GATA3 | chr8:143981134-143981524 | T-47D | breast: | n/a | n/a |
37 | HCFC1 | chr8:143993429-143993611 | K562 | blood: | n/a | n/a |
38 | HEY1 | chr8:143979414-143980147 | K562 | blood: | n/a | n/a |
39 | IRF4 | chr8:143979391-143980186 | GM12878 | blood: | n/a | n/a |
40 | IRF4 | chr8:143979516-143979822 | GM12878 | blood: | n/a | n/a |
41 | JUN | chr8:143984574-143984774 | K562 | blood: | n/a | n/a |
42 | JUND | chr8:143991527-143991650 | K562 | blood: | n/a | n/a |
43 | JUND | chr8:143979829-143980089 | HepG2 | liver: | n/a | n/a |
44 | MAFK | chr8:143983696-143983813 | HepG2 | liver: | n/a | chr8:143983728-143983743 |
45 | MAFK | chr8:143983704-143983817 | HepG2 | liver: | n/a | chr8:143983728-143983743 |
46 | MAX | chr8:143993376-143993691 | K562 | blood: | n/a | n/a |
47 | MAX | chr8:143997252-143997468 | K562 | blood: | n/a | chr8:143997357-143997372 |
48 | MAX | chr8:143997317-143997527 | A549 | lung: | n/a | chr8:143997357-143997372 |
49 | MAX | chr8:143993312-143994031 | MCF-7 | breast: | n/a | n/a |
50 | MAX | chr8:143993493-143993519 | NB4 | blood: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:143961341-143961391 | BJ | skin: | n/a |
2 | chr8:143961341-143961391 | BJ | skin: | n/a |
3 | chr8:143961341-143961391 | K562 | blood: | n/a |
4 | chr8:143961141-143961191 | ovcar-3 | ovarian: | n/a |
5 | chr8:143995000-143995050 | NB4 | blood: | n/a |
6 | chr8:143961291-143961341 | HRE | kidney: | n/a |
7 | chr8:143961391-143961441 | GM12878 | blood: | n/a |
8 | chr8:143961341-143961391 | HIPEpiC | eye: | n/a |
9 | chr8:143961145-143961195 | NT2-D1 | testis: | n/a |
10 | chr8:143961341-143961391 | LNCaP | prostate: | n/a |
11 | chr8:143961145-143961195 | NHDF-neo | bronchial: | n/a |
12 | chr8:143961291-143961341 | A549 | lung: | n/a |
13 | chr8:143961141-143961191 | HPAEpiC | pulmonary alveolar: | n/a |
14 | chr8:143961341-143961391 | HCF | heart: | n/a |
15 | chr8:143995000-143995050 | GM12878 | blood: | n/a |
16 | chr8:143961291-143961341 | HNPCEpiC | eye: | n/a |
17 | chr8:143961391-143961441 | NHDF-neo | bronchial: | n/a |
18 | chr8:143992652-143992702 | HCT-116 | colon: | n/a |
19 | chr8:143961141-143961191 | GM12891 | blood: | n/a |
20 | chr8:143961291-143961341 | T-47D | breast: | n/a |
21 | chr8:143992652-143992702 | SKMC | muscle: | n/a |
22 | chr8:143961291-143961341 | HEEpiC | esophagus: | n/a |
23 | chr8:143961391-143961441 | HEK293 | kidney: | embryo |
24 | chr8:143961141-143961191 | SK-N-SH | brain: | n/a |
25 | chr8:143961391-143961441 | LNCaP | prostate: | n/a |
26 | chr8:143961391-143961441 | NT2-D1 | testis: | n/a |
27 | chr8:143961141-143961191 | AG09319 | gingival: | n/a |
28 | chr8:143995000-143995050 | SAEC | small airway: | n/a |
29 | chr8:143961291-143961341 | IMR90 | lung: | fetal |
30 | chr8:143961341-143961391 | ECC-1 | luminal epithelium: | n/a |
31 | chr8:143961391-143961441 | AG09319 | gingival: | n/a |
32 | chr8:143992652-143992702 | MCF-7 | breast: | n/a |
33 | chr8:143961141-143961191 | GM12878 | blood: | n/a |
34 | chr8:143961291-143961341 | Jurkat | blood: | n/a |
35 | chr8:143992652-143992702 | HUVEC | blood vessel: | n/a |
36 | chr8:143961291-143961341 | Caco-2 | colon: | n/a |
37 | chr8:143961141-143961191 | CMK | blood: | n/a |
38 | chr8:143995000-143995050 | BE2_C | brain: | n/a |
39 | chr8:143992652-143992702 | AoSMC | blood vessel: | n/a |
40 | chr8:143961391-143961441 | T-47D | breast: | n/a |
41 | chr8:143961141-143961191 | SAEC | small airway: | n/a |
42 | chr8:143992652-143992702 | PrEC | prostate: | n/a |
43 | chr8:143995000-143995050 | Hela-S3 | cervix: | n/a |
44 | chr8:143961145-143961195 | AG09319 | gingival: | n/a |
45 | chr8:143961341-143961391 | AG04449 | skin: | fetal |
46 | chr8:143995000-143995050 | HCT-116 | colon: | n/a |
47 | chr8:143961141-143961191 | HAEpiC | amniotic membrane: | n/a |
48 | chr8:143992652-143992702 | NH-A | brain: | n/a |
49 | chr8:143961341-143961391 | H1-hESC | embryonic stem cell: | embryo |
50 | chr8:143961145-143961195 | BJ | skin: | n/a |
(count:7 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:143976851..143979156-chr8:143982564..143985353,2 | MCF-7 | breast: | |
2 | chr8:143928685..143930379-chr8:143986753..143989580,2 | K562 | blood: | |
3 | chr8:143982631..143984699-chr8:143987404..143990195,2 | K562 | blood: | |
4 | chr8:143970505..143972946-chr8:143997611..144000246,2 | MCF-7 | breast: | |
5 | chr8:143982631..143984699-chr8:143987404..143990195,2 | K562 | blood: | |
6 | chr8:143955912..143957781-chr8:143987320..143989042,2 | MCF-7 | breast: | |
7 | chr8:143976851..143979156-chr8:143982564..143985353,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
CYP11B1 | TF binding region |
CYP11B1 | CpG island |
ENSG00000160882 | chromatin interactions |
ENSG00000179142 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs200952801 | chr8:143961099-143961100 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs4534 | chr8:143961102-143961103 | Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs369213890 | chr8:143961103-143961104 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs193922538 | chr8:143961105-143961106 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs104894069 | chr8:143961106-143961107 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs397831740 | chr8:143961119-143961120 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs369941128 | chr8:143961121-143961122 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs201951316 | chr8:143961126-143961127 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs201103987 | chr8:143961141-143961142 | Enhancers Active TSS | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs140274628 | chr8:143961142-143961143 | Enhancers Active TSS | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs144224988 | chr8:143961145-143961146 | Enhancers Active TSS | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs147788769 | chr8:143961152-143961153 | Enhancers Active TSS | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs139569725 | chr8:143961153-143961154 | Enhancers Active TSS | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs61751134 | chr8:143961176-143961177 | Enhancers Active TSS | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs142591816 | chr8:143961180-143961181 | Enhancers Active TSS | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs150983560 | chr8:143961186-143961187 | Enhancers Active TSS | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs6405 | chr8:143961201-143961202 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs150163594 | chr8:143961205-143961206 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs200581194 | chr8:143961221-143961222 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs6389 | chr8:143961231-143961232 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs373827432 | chr8:143961249-143961250 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs539054150 | chr8:143961255-143961256 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs372954252 | chr8:143961263-143961264 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs5280 | chr8:143961293-143961294 | Weak transcription Flanking Active TSS Enhancers | CpG island | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs566126580 | chr8:143961356-143961357 | Weak transcription Flanking Active TSS Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs61751133 | chr8:143961379-143961380 | Weak transcription Flanking Active TSS Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs555013157 | chr8:143961380-143961381 | Weak transcription Flanking Active TSS Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs139302686 | chr8:143961415-143961416 | Weak transcription Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs573778824 | chr8:143961418-143961419 | Weak transcription Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs545376395 | chr8:143961423-143961424 | Weak transcription Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs544351684 | chr8:143961437-143961438 | Weak transcription Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs61751131 | chr8:143961445-143961446 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs577909770 | chr8:143961451-143961452 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs61751130 | chr8:143961454-143961455 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs575616487 | chr8:143961456-143961457 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs564501320 | chr8:143961473-143961474 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs555641291 | chr8:143961498-143961499 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs376350051 | chr8:143961508-143961509 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs528477303 | chr8:143961514-143961515 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs540744877 | chr8:143961544-143961545 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs377608641 | chr8:143961554-143961555 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs184235880 | chr8:143961572-143961573 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs529466650 | chr8:143961579-143961580 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs374288427 | chr8:143961583-143961584 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs567686896 | chr8:143961585-143961586 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs569340719 | chr8:143961604-143961605 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs533490091 | chr8:143961616-143961617 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs188187504 | chr8:143961624-143961625 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs146403087 | chr8:143961627-143961628 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs201613195 | chr8:143961631-143961632 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Gastric cancer | 17908304 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 17603634 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Breast cancer | 17899364 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Developmental delay | 21147756 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Papillary thyroid cancer | 17515504 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Breast cancer | 22532251 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21129771 | CNVD |
benign familial neonatal convulsions | 18472482 | CNVD |
Breast cancer | 16417655 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21183584 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Breast cancer | 20814816 | CNVD |
Colorectal cancer | 22486879 | CNVD |
Breast cancer | 17908964 | CNVD |
Colorectal cancer | 20031965 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Ovarian cancer | 17908964 | CNVD |
Ovarian cancer | 20031965 | CNVD |
Prostate cancer | 20031965 | CNVD |
Non-small cell lung cancer | 17643093 | CNVD |
Prostate cancer | 19242612 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Multiple myeloma | 16616336 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21364760 | CNVD |
Pilocytic astrocytoma | 18622384 | CNVD |
Pilomyxoid astrocytoma | 18622384 | CNVD |
Gastric cancer | 24379144 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 20409316 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Glioma | 17123091 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Lung cancer | 17086460 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
head and neck squamous cell carcinoma | 16740747 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Astrocytoma | 22246337 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Breast cancer | 21806811 | CNVD |
Chylomicronemia | 22008945 | CNVD |
Heart disease | 21282601 | CNVD |
Chordoma | 21602918 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Breast cancer | 16397240 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Cancer | 20164920 | CNVD |
Oral cancer | 22144094 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Cancer | 20581869 | CNVD |
Oral squamous cell carcinoma | 21853135 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Prostate cancer | 22341455 | CNVD |
T-cell lymphomas | 22341440 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:143960800-143961200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr8:143961000-143961200 | Active TSS | Fetal Adrenal Gland | Adrenal Gland |
3 | chr8:143961000-143961400 | Enhancers | Spleen | Spleen |
4 | chr8:143961200-143961400 | Flanking Active TSS | Fetal Adrenal Gland | Adrenal Gland |
5 | chr8:143961200-143969800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr8:143961400-143961800 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
7 | chr8:143969800-143970400 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
8 | chr8:143970400-143992600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr8:143975000-143975600 | Enhancers | Duodenum Mucosa | Duodenum |
10 | chr8:143975800-143976000 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
11 | chr8:143976000-143977400 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
12 | chr8:143977400-143977600 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
13 | chr8:143979000-143979600 | Enhancers | Cortex derived primary cultured neurospheres | brain |
14 | chr8:143988000-143989200 | Enhancers | HepG2 | liver |
15 | chr8:143991200-143991600 | Enhancers | Primary T cells fromperipheralblood | blood |
16 | chr8:143991200-143991600 | Enhancers | Primary T killer naive cells fromperipheralblood | blood |
17 | chr8:143991200-143992200 | Enhancers | Spleen | Spleen |
18 | chr8:143991400-143992000 | Enhancers | Primary B cells from peripheral blood | blood |
19 | chr8:143992200-143993200 | Weak transcription | Spleen | Spleen |
20 | chr8:143992600-143993400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
21 | chr8:143993200-143993400 | Enhancers | Spleen | Spleen |
22 | chr8:143993400-143993600 | Enhancers | Foreskin Fibroblast Primary Cells skin02 | Skin |
23 | chr8:143993400-143993600 | Genic enhancers | Spleen | Spleen |
24 | chr8:143993400-143993800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
25 | chr8:143993600-143995000 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
26 | chr8:143993600-143995200 | Weak transcription | Spleen | Spleen |
27 | chr8:143993800-143994200 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
28 | chr8:143994200-144003200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
29 | chr8:143994400-143994600 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
30 | chr8:143994800-143995400 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
31 | chr8:143995000-143995400 | Enhancers | Foreskin Fibroblast Primary Cells skin02 | Skin |
32 | chr8:143995200-143996000 | Enhancers | Spleen | Spleen |
33 | chr8:143995400-143995600 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
34 | chr8:143996000-144003000 | Weak transcription | Spleen | Spleen |